On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
This is the first update to the original CTS communication distributed on July 6th. As previously co...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...